Cutaneous squamous-cell carcinoma of the head-neck area refractory to chemo-radiotherapy: benefit from anti-PD-1 immunotherapy

OBJECTIVE: Radiotherapy provides excellent results in locally advanced cutaneous squamous-cell carcinoma of the head and neck area (cSCC-HN), with a 2-year local progression-free interval obtained for about 80% of patients. Overexpression of immune checkpoint co-inhibitory molecules, like PD-L1 (pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Koukourakis, Ioannis M., Giakzidis, Axiotis G., Kouroupi, Maria, Giatromanolaki, Alexandra, Abatzoglou, Ioannis, Karpouzis, Antonios, Koukourakis, Michael I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171141/
https://www.ncbi.nlm.nih.gov/pubmed/34131497
http://dx.doi.org/10.1259/bjrcr.20200170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171141/
https://www.ncbi.nlm.nih.gov/pubmed/34131497
http://dx.doi.org/10.1259/bjrcr.20200170

Ejemplares similares